Moderna
MRNA
#1274
Rank
S$18.97 B
Marketcap
$49.32
Share price
-0.51%
Change (1 day)
-53.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$5.20 Billion

According to Moderna 's latest financial reports the company's total liabilities are S$5.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$6.03 B-33.12%
2022-12-31S$9.02 B-36.54%
2021-12-31S$14.22 B125.18%
2020-12-31S$6.31 B1030.35%
2019-12-31S$0.55 B-5.27%
2018-12-31S$0.59 B-3.93%
2017-12-31S$0.61 B-26.24%
2016-12-31S$0.83 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$7.96 M-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$97.93 B 1,782.66%๐Ÿ‡บ๐Ÿ‡ธ USA
S$58.81 M-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.60 B 7.65%๐Ÿ‡บ๐Ÿ‡ธ USA
S$80.63 B 1,450.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$0.73 B-85.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$145.11 B 2,689.71%๐Ÿ‡บ๐Ÿ‡ธ USA